Dr. Agarwals Health Care Ltd (AGARWALEYE) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Dr. Agarwals achieved record-breaking results, exceeding INR 500 crores in total income for Q1 FY26.
- Profit after tax more than doubled to INR 38 crores, a 100% year-on-year increase.
- Total income reached INR 501 crores, a 22.3% year-on-year growth, while revenue from operations rose by 20.8% to INR 487 crores.
- Robust EBITDA of INR 141 crores, marking a 28.9% year-on-year growth, with margins at 28.2%, a 140 basis point improvement.
- Expanded footprint with 13 new greenfield facilities, including a strategic entry into the Delhi market.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.